Cargando...
CRISPR/Cas9 genome editing in human hematopoietic stem cells
Genome editing via homologous recombination (HR) (gene targeting) in human hematopoietic stem cells (HSCs) has the power to reveal gene–function relationships and potentially transform curative hematological gene and cell therapies. However, there are no comprehensive and reproducible protocols for...
Gardado en:
| Publicado en: | Nat Protoc |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5826598/ https://ncbi.nlm.nih.gov/pubmed/29370156 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nprot.2017.143 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|